Exact Sciences Corp
EXASDelisted Mar 23, 2026- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001124140
Exact Sciences Corp was delisted on Mar 23, 2026; its insiders filed their last Form 4 on Mar 23, 2026; 712 institutions reported holding it in 13F filings for Q4 2025, worth $17.9B in total; superinvestors Soros Fund Management and ARK Invest held it.
13F holders, Q2 2024
Institutional positions in Exact Sciences Corp as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 545
- −74 vs. Q1 2024
- Shares held
- 179.1M
- +15.7M (+9.6%) vs. Q1 2024
- Total value
- $7.57B
- −$3.69B (−32.8%) vs. Q1 2024
- New holders
- 63
- 212 more added
- Sold out
- 137
- 179 more reduced
6 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting EXAS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $1.81K |
| Q1 2026 | 7 | $4.92M |
| Q4 2025 | 712 | $17.9B |
| Q3 2025 | 570 | $9.70B |
| Q2 2025 | 558 | $9.49B |
| Q1 2025 | 557 | $7.89B |
| Q4 2024 | 594 | $10.3B |
| Q3 2024 | 601 | $12.4B |
| Q2 2024 | 545 | $7.57B |
| Q1 2024 | 625 | $11.3B |
| Q4 2023 | 647 | $11.9B |
| Q3 2023 | 626 | $11.2B |
| Q2 2023 | 655 | $15.3B |
| Q1 2023 | 585 | $11.1B |
| Q4 2022 | 552 | $8.11B |
| Q3 2022 | 480 | $5.26B |
| Q2 2022 | 502 | $6.56B |
| Q1 2022 | 558 | $11.7B |
| Q4 2021 | 596 | $12.5B |
| Q3 2021 | 603 | $15.1B |
| Q2 2021 | 624 | $19.2B |
| Q1 2021 | 646 | $20.2B |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Exact Sciences Corp; share changes are against Q1 2024.